Theravance Biopharma Announces Tender Offer For Outstanding 3.25% Convertible Senior Notes Due 2023
/PRNewswire/ -- Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today announced a tender offer (the "Offer") to purchase...
New York United States Theravance Biopharma Gail Cohen Company Offer To Purchase Theravance Biopharma Inc
Source: prnewswire.com